Pendred syndrome and iodide transport in the thyroid

Trends in Endocrinology and Metabolism

Volumn 19, Issue 7, 2008, Pages 260-268

  Kopp, Peter ^a   Pesce, Liuska ^a,b   Solis S, Juan Carlos ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODIDE; MESSENGER RNA; PENDRIN; THYROID HORMONE;

CLINICAL FEATURE; GENE; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY; HORMONE SYNTHESIS; HUMAN; INNER EAR; KIDNEY; MULTIGENE FAMILY; NONHUMAN; PENDRED SYNDROME; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SLC26A4 GENE; THYROID CELL; THYROID FOLLICLE; THYROID GLAND; TRANSPORT KINETICS;

GOITER; HEARING LOSS, SENSORINEURAL; HUMANS; IODIDES; MEMBRANE TRANSPORT PROTEINS; SYNDROME; THYROID GLAND;

EID: 49649096773     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2008.07.001     Document Type: Review

References (81)

1. Pendred V. Deaf-mutism and goitre. Lancet ii (1896) 532
2. Morgans M.E., and Trotter W.R. Association of congenital deafness with goitre: the nature of the thyroid defect. Lancet 1 (1958) 607-609
3. Fraser G.R., et al. The syndrome of sporadic goitre and congenital deafness. Q. J. Med. 29 (1960) 279-295
4. Medeiros-Neto G., and Stanbury J.B. Pendred's syndrome: association of congenital deafness with sporadic goiter. In: Medeiros-Neto G., and Stanbury J.B. (Eds). Inherited Disorders of the Thyroid System (1994), CRC Press 81-105
5. Everett L.A., et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet. 17 (1997) 411-422
6. Kopp P. Pendred's syndrome: clinical characteristics and molecular basis. Curr. Opin. Endocrinol. Diabetes 6 (1999) 261-269
7. Reardon W., et al. Pendred syndrome: 100 years of underascertainement. Q. J. Med. 90 (1997) 443-447
8. Campbell C., et al. Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum. Mutat. 17 (2001) 403-411
9. Cremers C.W.R.J., et al. Progressive sensorineural hearing loss and a widened vestibular aqueduct in Pendred syndrome. Arch. Otolaryngol. Head Neck Surg. 124 (1998) 501-505
10. Phelps P.D., et al. Radiological malformations of the ear in Pendred syndrome. Clin. Radiol. 53 (1998) 268-273
11. Fugazzola L., et al. Molecular analysis of the Pendred's syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred's syndrome. J. Clin. Endocrinol. Metab. 85 (2000) 2469-2475
12. Pryor S.P., et al. SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J. Med. Genet. 42 (2005) 159-165
13. Hartley G.J., and Phelps P.D. The anatomical section of a boy born deaf (Mondini translation). Am. J. Otol. 18 (1997) 288-293
14. Nilsson L.R., et al. Non-endemic goitre and deafness. Acta Paediatr. 53 (1964) 117-131
15. Fraser G.R. Association of congenital deafness with goitre (Pendred's syndrome). Ann. Hum. Genet. 28 (1965) 201-249
16. Gausden E., et al. Pendred syndrome: evidence for genetic homogeneity and further refinement of linkage. J. Med. Genet. 34 (1997) 126-129
17. Sato E., et al. Phenotypes associated with replacement of His by Arg in the Pendred syndrome gene. Eur. J. Endocrinol. 145 (2001) 697-703
18. Usami S., et al. Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum. Genet. 104 (1999) 188-192
19. Baschieri L., et al. Evaluation and limitations of the perchlorate test in the study of thyroid function. J. Clin. Endocrinol. Metab. 23 (1963) 786-791
20. Gillam M.P., et al. Functional characterization of pendrin in a polarized cell system: evidence for pendrin-mediated apical iodide efflux. J. Biol. Chem. 279 (2004) 13004-13010
21. Kopp P. Thyroid hormone synthesis: thyroid iodine metabolism. In: Braverman L., and Utiger R. (Eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text (2005), Lippincott, Williams & Wilkins 52-76
22. Trotter W.R. The association of deafness with thyroid dysfunction. Br. Med. Bull. 16 (1960) 92-98
23. Kopp P., et al. Phenocopies for deafness and goiter development in a large inbred kindred with Pendred's syndrome caused by a novel mutation in the PDS gene. J. Clin. Endocrinol. Metab. 84 (1999) 336-341
24. Gonzalez Trevino O., et al. Clinical and molecular analysis of three Mexican families with Pendred's syndrome. Eur. J. Endocrinol. 144 (2001) 1-9
25. Everett L.A., and Green E.D. A family of mammalian anion transporters and their involvement in human genetic diseases. Hum. Mol. Genet. 8 (1999) 1883-1891
26. Mount D.B., and Romero M.F. The SLC26 gene family of multifunctional anion exchangers. Pflugers Arch. 447 (2004) 710-721
27. Dawson P.A., and Markovich D. Pathogenetics of the human SLC26 transporters. Curr. Med. Chem. 12 (2005) 385-396
28. Zheng J., et al. Prestin is the motor protein of cochlear outer hair cells. Nature 405 (2000) 149-155
29. Oliver D., et al. Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein. Science 292 (2001) 2340-2343
30. Scott D.A., et al. The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat. Genet. 21 (1999) 440-443
31. - exchanger in the kidney cortex. Am. J. Physiol. Renal Physiol. 280 (2001) F356-F364
32. Royaux I.E., et al. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4221-4226
33. Yoshida A., et al. Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J. Clin. Endocrinol. Metab. 87 (2002) 3356-3361
34. Taylor J.P., et al. Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndrome. J. Clin. Endocrinol. Metab. 87 (2002) 1778-1784
35. Royaux I.E., et al. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141 (2000) 839-845
36. Aravind L., and Koonin E.V. The STAS domain - a link between anion transporters and antisigma-factor antagonists. Curr. Biol. 10 (2001) R53-R55
37. Ko S.B., et al. A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J. 21 (2002) 5662-5672
38. Ko S.B., et al. Gating of CFTR by the STAS domain of SLC26 transporters. Nat. Cell Biol. 6 (2004) 343-350
39. Shcheynikov N., et al. Regulatory interaction between CFTR and the SLC26 transporters. Novartis Found. Symp. 273 (2006) 177-186 discussion 186-192, 261-264
40. Gillam M.P., et al. Molecular analysis of the PDS gene in a nonconsanguineous Sicilian family with Pendred's syndrome. Thyroid 15 (2005) 734-741
41. Dossena S., et al. Fast fluorometric method for measuring pendrin (SLC26A4) Cl-/I- transport activity. Cell. Physiol. Biochem. 18 (2006) 67-74
42. Rotman-Pikielny P., et al. Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. Hum. Mol. Genet. 11 (2002) 2625-2633
43. Schnyder, S. et al. (2005) Pendrin mutations that are retained in intracellular compartments induce the IRE1/XBP1 and the ATF6 unfolded protein response pathways. Thyroid 7th International Thyroid Congress. Buenos Aires, Argentina., Abstract
44. Everett L.A., et al. Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9727-9732
45. Everett L.A., et al. Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum. Mol. Genet. 10 (2001) 153-161
46. Wangemann P., et al. Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med. 2 (2004) 30
47. Wangemann P., et al. Loss of cochlear HCO3- secretion causes deafness via endolymphatic acidification and inhibition of Ca2+ reabsorption in a Pendred syndrome mouse model. Am. J. Physiol. Renal Physiol. 292 (2007) F1345-F1353
48. Nakaya K., et al. Lack of pendrin HCO3- transport elevates vestibular endolymphatic [Ca2+] by inhibition of acid-sensitive TRPV5 and TRPV6 channels. Am. J. Physiol. Renal Physiol. 292 (2007) F1314-F1321
49. Dohan O., et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr. Rev. 24 (2003) 48-77
50. Wolff J. Transport of iodide and other anions in the thyroid gland. Physiol. Rev. 44 (1964) 45-90
51. Arvan P., and Di Jeso B. Thyroglobulin structure, function, and biosynthesis. In: Braverman L., and Utiger R. (Eds). Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text (2005), Lippincott, Williams & Wilkins 77-95
52. Moreno J.C. Identification of novel genes involved in congenital hypothyroidism using serial analysis of gene expression. Horm. Res. 60 Suppl 3 (2003) 96-102
53. Golstein P., et al. The iodide channel of the thyroid: a plasma membrane vesicle study. Am. J. Physiol. 263 (1992) C590-C597
54. Bidart J.M., et al. Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J. Clin. Endocrinol. Metab. 85 (2000) 2028-2033
55. Yoshida A., et al. Mechanism of iodide/chloride exchange by pendrin. Endocrinology 145 (2004) 4301-4308
56. 2+. Endocrinology 114 (1984) 1108-1113
57. Nilsson M., et al. Iodide transport in primary cultured thyroid follicle cells: evidence of a TSH-regulated channel mediating iodide efflux selectively across the apical domain of the plasma membrane. Eur. J. Cell Biol. 52 (1990) 270-281
58. Nilsson M., et al. Polarized efflux of iodide in porcine thyrocytes occurs via a cAMP-regulated iodide channel in the apical plasma membrane. Acta Endocrinol. (Copenh.) 126 (1992) 67-74
59. Pesce, L. and Kopp, P. (2007) Thyrotropin rapidly regulates pendrin membrane abundance via PKA dependent and PKC independent pathways in rat thyroid cells. Thyroid 78th Annual Meeting of the American Thyroid Association. New York, NY. Abstract
60. Dentice M., et al. Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol. Cell. Biol. 25 (2005) 10171-10182
61. Solis-S, J. et al. (2006) Synergistic stimulation of the human PDS/SLC26A4 promoter by PAX8 and TTF1. 16, 77th Annual meeting of the American Thyroid Association. Phoenix, AZ. 861, Abstract 814
62. Suzuki K., et al. Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2285-2290
63. Suzuki K., et al. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology 140 (1999) 5422-5430
64. Suzuki K., et al. In vivo expression of thyroid transcription factor-1 RNA and its relation to thyroid function and follicular heterogeneity: identification of follicular thyroglobulin as a feedback suppressor of thyroid transcription factor-1 RNA levels and thyroglobulin synthesis. Thyroid 9 (1999) 319-331
65. Suzuki K., and Kohn L.D. Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J. Endocrinol. 189 (2006) 247-255
66. Solis-S, J. et al. (2007) Regulation of thyroidal transcripts and the human PDS/SLC26A4 promoter by thyroglobulin. 78th Annual Meeting of the American Thyroid Association. New York, NY. Abstract.
67. Kohn L.D., et al. Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte. Trends Endocrinol. Metab. 12 (2001) 10-16
68. Wolff J. What is the role of pendrin?. Thyroid 15 (2005) 346-348
69. Andros G., and Wollman S.H. Autoradiographic Localization of Iodide-125 in the Thyroid Epithelial Cell. Proc. Soc. Exp. Biol. Med. 115 (1964) 775-777
70. Rodriguez A.M., et al. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J. Clin. Endocrinol. Metab. 87 (2002) 3500-3503
71. Paroder V., et al. Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7270-7275
72. van den Hove M.F., et al. The loss of the chloride channel, ClC-5, delays apical iodide efflux and induces a euthyroid goiter in the mouse thyroid gland. Endocrinology 147 (2006) 1287-1296
73. Wall S.M. Recent advances in our understanding of intercalated cells. Curr. Opin. Nephrol. Hypertens. 14 (2005) 480-484
74. Scott D.A., and Karniski L.P. Human pendrin expressed in Xenopus laevis oocytes mediates chloride/formate exchange. Am. J. Physiol. Cell Physiol. 278 (2000) C207-C211
75. Verlander J.W., et al. Deoxycorticosterone upregulates PDS (Slc26a4) in mouse kidney: role of pendrin in mineralocorticoid-induced hypertension. Hypertension 42 (2003) 356-362
76. Verlander J.W., et al. Dietary Cl- restriction upregulates pendrin expression within the apical plasma membrane of type B intercalated cells. Am. J. Physiol. Renal Physiol. 291 (2006) F833-F839
77. Kim Y.H., et al. Reduced ENaC protein abundance contributes to the lower blood pressure observed in pendrin-null mice. Am. J. Physiol. Renal Physiol. 293 (2007) F1314-F1324
78. Delange F., et al. Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biol. Neonate 49 (1986) 322-330
79. Rillema J.A., and Hill M.A. Prolactin regulation of the pendrin-iodide transporter in the mammary gland. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E25-E28
80. Lacroix L., et al. Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters. J. Clin. Endocrinol. Metab. 89 (2004) 1423-1428
81. Pedemonte N., et al. Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: role of pendrin and anion channels. J. Immunol. 178 (2007) 5144-5153